Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

4.87USD
22 Jul 2014
Price Change (% chg)

$-0.06 (-1.22%)
Prev Close
$4.93
Open
$4.96
Day's High
$5.13
Day's Low
$4.82
Volume
303,426
Avg. Vol
282,519
52-wk High
$7.45
52-wk Low
$3.15

PGNX.OQ

Chart for PGNX.OQ

About

Progenics Pharmaceuticals, Inc. (Progenics) is a biopharmaceutical company focuses on research and development for biotechnology product candidates in oncology, virology, supportive care and gastroenterology. It is also engaged in research to identify multiplex phosphoinositide 3-kinase inhibitors for blocking signaling pathways... (more)

Overall

Beta: 1.48
Market Cap (Mil.): $338.74
Shares Outstanding (Mil.): 69.56
Dividend: --
Yield (%): --

Financials

  PGNX.OQ Industry Sector
P/E (TTM): -- 35.48 35.85
EPS (TTM): -0.70 -- --
ROI: -34.68 18.97 18.25
ROE: -46.38 19.75 19.12
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks